RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 91 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $473 | +42.9% | 20,641 | +2.7% | 0.00% | – |
| Q2 2023 | $331 | +1642.1% | 20,100 | +1775.0% | 0.00% | – |
| Q1 2023 | $19 | -38.7% | 1,072 | 0.0% | 0.00% | – |
| Q4 2022 | $31 | -99.9% | 1,072 | 0.0% | 0.00% | – |
| Q3 2022 | $26,000 | +2500.0% | 1,072 | +241.4% | 0.00% | – |
| Q2 2022 | $1,000 | -99.7% | 314 | -99.0% | 0.00% | – |
| Q1 2022 | $352,000 | +15.4% | 30,582 | +0.0% | 0.00% | – |
| Q4 2021 | $305,000 | -33.6% | 30,576 | -13.0% | 0.00% | – |
| Q3 2021 | $459,000 | -41.5% | 35,165 | -12.3% | 0.00% | -100.0% |
| Q2 2021 | $785,000 | +5.4% | 40,107 | +14.6% | 0.00% | 0.0% |
| Q1 2021 | $745,000 | -19.2% | 35,005 | +12.9% | 0.00% | 0.0% |
| Q4 2020 | $922,000 | +27.7% | 31,005 | -6.9% | 0.00% | 0.0% |
| Q3 2020 | $722,000 | -2.8% | 33,305 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $743,000 | +66.6% | 33,305 | +13.6% | 0.00% | 0.0% |
| Q1 2020 | $446,000 | -17.4% | 29,305 | +24.7% | 0.00% | 0.0% |
| Q4 2019 | $540,000 | +6.5% | 23,505 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $507,000 | -1.9% | 23,505 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $517,000 | +10.2% | 23,505 | +37.4% | 0.00% | 0.0% |
| Q1 2019 | $469,000 | +2.0% | 17,105 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $460,000 | +15.9% | 17,105 | +25.7% | 0.00% | – |
| Q3 2018 | $397,000 | -6.6% | 13,605 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $425,000 | +160.7% | 13,605 | +65.8% | 0.00% | – |
| Q1 2018 | $163,000 | -22.0% | 8,205 | +14.0% | 0.00% | – |
| Q4 2017 | $209,000 | – | 7,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |